Loading...
Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis
OBJECTIVE: To examine whether rituximab induction followed by glatiramer acetate (GA) monotherapy is more effective than GA alone for the treatment of relapsing multiple sclerosis with active disease. METHODS: This was a single-center, double-blind, placebo-controlled study. Fifty-five participants...
Na minha lista:
| Udgivet i: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382366/ https://ncbi.nlm.nih.gov/pubmed/30635477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000006916 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|